Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2005 4
2006 3
2007 3
2008 3
2009 1
2011 3
2012 1
2013 2
2014 3
2015 4
2016 6
2017 2
2018 2
2019 3
2020 2
2021 2
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation.
Sadras I, Kerem E, Livnat G, Sarouk I, Breuer O, Reiter J, Gileles-Hillel A, Inbar O, Cohen M, Gamliel A, Stanleigh N, Gunawardena T, Bartlett C, Gonska T, Moraes T, Eckford PDW, Bear CE, Ratjen F, Kerem B, Wilschanski M, Shteinberg M, Cohen-Cymberknoh M. Sadras I, et al. Among authors: kerem b. J Cyst Fibros. 2023 Nov;22(6):1062-1069. doi: 10.1016/j.jcf.2023.06.001. Epub 2023 Jun 16. J Cyst Fibros. 2023. PMID: 37331863
DNA replication stress drives fragile site instability.
Irony-Tur Sinai M, Kerem B. Irony-Tur Sinai M, et al. Among authors: kerem b. Mutat Res. 2018 Mar;808:56-61. doi: 10.1016/j.mrfmmm.2017.10.002. Epub 2017 Oct 18. Mutat Res. 2018. PMID: 29074228 Review.
Genomic instability in fragile sites-still adding the pieces.
Irony-Tur Sinai M, Kerem B. Irony-Tur Sinai M, et al. Among authors: kerem b. Genes Chromosomes Cancer. 2019 May;58(5):295-304. doi: 10.1002/gcc.22715. Epub 2018 Dec 26. Genes Chromosomes Cancer. 2019. PMID: 30525255 Review.
New approaches to genetic therapies for cystic fibrosis.
Christopher Boyd A, Guo S, Huang L, Kerem B, Oren YS, Walker AJ, Hart SL. Christopher Boyd A, et al. Among authors: kerem b. J Cyst Fibros. 2020 Mar;19 Suppl 1:S54-S59. doi: 10.1016/j.jcf.2019.12.012. Epub 2020 Jan 13. J Cyst Fibros. 2020. PMID: 31948871 Free article. Review.
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.
Orenti A, Pranke I, Faucon C, Varilh J, Hatton A, Golec A, Dehillotte C, Durieu I, Reix P, Burgel PR, Grenet D, Tasset C, Gachelin E, Perisson C, Lepissier A, Dreano E, Tondelier D, Chevalier B, Weiss L, Kiefer S, Laurans M, Chiron R, Lemonnier L, Marguet C, Jung A, Edelman A, Kerem BS, Girodon E, Taulan-Cadars M, Hinzpeter A, Kerem E, Naehrlich L, Sermet-Gaudelus I; ECFSPR Steering group. Orenti A, et al. J Cyst Fibros. 2023 Nov;22(6):1070-1079. doi: 10.1016/j.jcf.2023.06.005. Epub 2023 Jul 6. J Cyst Fibros. 2023. PMID: 37422433
AT-dinucleotide rich sequences drive fragile site formation.
Irony-Tur Sinai M, Salamon A, Stanleigh N, Goldberg T, Weiss A, Wang YH, Kerem B. Irony-Tur Sinai M, et al. Among authors: kerem b. Nucleic Acids Res. 2019 Oct 10;47(18):9685-9695. doi: 10.1093/nar/gkz689. Nucleic Acids Res. 2019. PMID: 31410468 Free PMC article.
54 results